ID   A00673; SV 1; linear; unassigned DNA; PAT; SYN; 45 BP.
XX
AC   A00673;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   Artificial sequence for plasmid pSV-V-NP gamma-SNase
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; patent; regular; unassigned DNA; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-45
RA   Neuberger M.S.;
RT   "PRODUCTION OF CHIMERIC ANTIBODIES";
RL   Patent number WO8601533-A/2, 13-MAR-1986.
RL   CellTech Ltd..
XX
DR   ENA; A00673.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..45
FT                   /organism="synthetic construct"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32630"
FT   exon            8..>45
FT   intron          <1..7
XX
SQ   Sequence 45 BP; 14 A; 13 C; 7 G; 11 T; 0 other;
     tcatcagctc ctaacctcga ggatccaaca gtatatagtg caact                        45
//
ID   A01650; SV 1; linear; unassigned DNA; PAT; SYN; 45 BP.
XX
AC   A01650;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   Synthetic IG-D-segment fragment
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; diversity; patent; regular; unassigned DNA; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-45
RA   ;
RT   "PRODUCTION OF ANTIBODIES FROM TRANSGENIC ANIMALS";
RL   Patent number WO9004036-A/1, 19-APR-1990.
XX
DR   ENA; A01650.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..45
FT                   /organism="synthetic construct"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32630"
FT   misc_feature    1..45
FT                   /note="D-seqment"
XX
SQ   Sequence 45 BP; 10 A; 12 C; 12 G; 11 T; 0 other;
     gcgtcaccgt ggtagctgct accgtagtaa taaacactgt ggtcc                        45
//
ID   A01651; SV 1; linear; unassigned DNA; PAT; SYN; 39 BP.
XX
AC   A01651;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   Synthetic IG-D-segment fragment
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; diversity; patent; regular; unassigned DNA; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-39
RA   ;
RT   "PRODUCTION OF ANTIBODIES FROM TRANSGENIC ANIMALS";
RL   Patent number WO9004036-A/2, 19-APR-1990.
XX
DR   ENA; A01651.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..39
FT                   /organism="synthetic construct"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32630"
FT   misc_feature    1..39
FT                   /note="D-segment"
XX
SQ   Sequence 39 BP; 8 A; 10 C; 12 G; 9 T; 0 other;
     gcgtcaccgt ggtcgtaacc atagtagaca ctgtggtgc                               39
//
ID   A02055; SV 1; linear; unassigned DNA; PAT; SYN; 45 BP.
XX
AC   A02055;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   Artificial sequence for plasmid PSV-V-NP gamma-Klenow
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; diversity; patent; regular; unassigned DNA; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-45
RA   Neuberger M.S.;
RT   "PRODUCTION OF CHIMERIC ANTIBODIES";
RL   Patent number WO8601533-A/6, 13-MAR-1986.
RL   CellTech Ltd..
XX
DR   ENA; A02055.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..45
FT                   /organism="synthetic construct"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32630"
FT   intron          <1..7
FT   exon            8..>45
XX
SQ   Sequence 45 BP; 9 A; 14 C; 11 G; 11 T; 0 other;
     tcatcagctc ctaacctcga cggatccggg gcaacggtga tttct                        45
//
ID   A02359; SV 1; linear; unassigned DNA; PAT; MUS; 1931 BP.
XX
AC   A02359;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   M.musculus IgG gamma 2b gene.
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; constant; patent; regular; unassigned DNA; undefined.
XX
OS   Mus musculus (house mouse)
OC   cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria;
OC   Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi;
OC   Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota;
OC   Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Glires;
OC   Rodentia; Sciurognathi; Muroidea; Muridae; Murinae; Mus; Mus; Mus musculus.
XX
RN   [1]
RP   1-1931
RA   ;
RT   "ALTERED ANTIBODIES";
RL   Patent number WO8807089-A/1, 22-SEP-1988.
XX
DR   ENA; A02359.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..1931
FT                   /organism="Mus musculus"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:10090"
FT   misc_feature    173..463
FT                   /gene="IgG gamma 2b"
FT                   /note="CH1 domain"
FT   misc_feature    780..843
FT                   /gene="IgG gamma 2b"
FT                   /note="hinge"
FT   misc_feature    953..1282
FT                   /gene="IgG gamma 2b"
FT                   /note="CH2 domain"
FT   misc_feature    1395..1715
FT                   /gene="IgG gamma 2b"
FT                   /note="CH3 domain"
XX
SQ   Sequence 1931 BP; 537 A; 530 C; 445 G; 419 T; 0 other;
     aacatggaaa aattaaggtc acagtgcaag ctctggaggc ggaaatttct gacactgctt        60
     gcctcagatc aattgtagaa gacacggttc taagagcaaa gctaagaaca gaatctctcc       120
     aaatatccga ggccactgat aagaaaaagc tcacacattc tcctctcttg cagccaaaac       180
     aacaccccca tcagtctatc cactggcccc tgggtgtgga gatacaactg gttcctccgt       240
     gactctggga tgcctggtca agggctactt ccctgagtca gtgactgtga cttggaactc       300
     tggatccctg tccagcagtg tgcacacctt cccagctctc ctgcagtctg gactctacac       360
     tatgagcagc tcagtgactg tcccctccag cacttggcca agtcagaccg tcacctgcag       420
     cgttgctcac ccagccagca gcaccacggt ggacaaaaaa cttggtgaga ggacattcag       480
     gggaggaggg attcaccaga gttgaggcaa aggtattagc ctatctaaac cagccaggct       540
     gggatccatc accaaggagg tgaccttagc ccagggaaga gggagatact gtctctgcct       600
     ccctcctggg aacatctagc tatgaccacc tacactcaag gacatgttcc tctgggatag       660
     gtgtgcttgt catttccagg atcatcctgg aactaagccc ataccaggac aaactttcct       720
     ctctctggtt tggtgcttct ctccttcaaa aaccagtaac atccagcctt ctctctgcag       780
     agcccagcgg gcccatttca acaatcaacc cctgtcctcc atgcaaggag tgtcacaaat       840
     gcccaggtaa gtcactacca gagctccact cccaggagaa tggtaagtgc tgtaaaaatc       900
     cctgtaatgg aggataagcc atgtacaaat ccatttccat ctctcctcat cagctcctaa       960
     cctcgagggt ggaccatccg tcttcatctt ccctccaaat atcaaggatg tactcatgat      1020
     ctccctgaca cccaaggtca cgtgtgtggt ggtggatgtg agcgaggatg acccagacgt      1080
     ccagatcagc tggtttgtga acaacgtgga agtacacaca gctcagacac aaacccatag      1140
     agaggattac aacagtacta tccgggtggt cagcaccctc cccatccagc accaggactg      1200
     gatgagtggc aaggagttca aatgcaaggt caacaacaaa gacctcccat cacccatcga      1260
     gagaaccatc tcaaaaatta aaggtgggac ctgcaggaca actgcatggg ggctgggatg      1320
     ggcataagaa taaatgtcta tgtggacagc cttccacttc agccatgacc tctatgtatg      1380
     tttctaaccc cacagggcta gtcagagctc cacaagtata catcttgccg ccaccagcag      1440
     agcagttgtc caggaaagat gtcagtctca cttgcctggt cgtgggcttc aaccctggag      1500
     acatcagtgt ggagtggacc agcaatgggc atacagagga gaactacaag gacaccgcac      1560
     cagtcctaga ctctgacggt tcttacttca tatatagcaa gctcaatatg aaaacaagca      1620
     agtgggagaa aacagattcc ttctcatgca acgtgagaca cgagggtctg aaaaattact      1680
     acctgaagaa gaccatctcc cggtctccgg gtaaatgagc tcagcaccca caaagctctc      1740
     aggtcctaag agacactggc acccatatcc atgcatccct tgtataaata aagcatccag      1800
     caaagcctgg taccatgtaa aactgtcctg gttctttcca aggtatagag catagctcac      1860
     gggctgatag gtctggccag ggccggagaa cagccttgtc tataggaaga gaatgaggtt      1920
     tctgcctgca t                                                           1931
//
ID   A02365; SV 1; linear; unassigned DNA; PAT; HUM; 240 BP.
XX
AC   A02365;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   H.sapiens gamma 3 gene.
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; constant; patent; regular; unassigned DNA; undefined.
XX
OS   Homo sapiens (human)
OC   cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria;
OC   Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi;
OC   Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota;
OC   Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates;
OC   Haplorrhini; Simiiformes; Catarrhini; Hominoidea; Hominidae; Homininae;
OC   Homo; Homo sapiens.
XX
RN   [1]
RP   1-240
RA   ;
RT   "ALTERED ANTIBODIES";
RL   Patent number WO8807089-A/7, 22-SEP-1988.
XX
DR   ENA; A02365.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..240
FT                   /organism="Homo sapiens"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:9606"
XX
SQ   Sequence 240 BP; 47 A; 76 C; 67 G; 50 T; 0 other;
     gccctagagt ggcctgcatc cagggacagg tcccagtcgg gtgctgacac atctgcctcc        60
     atctcttcct cagcacctga actcctggga ggaccgtcag tcttcctctt ccccccaaaa       120
     cccaaggata cccttatgat ttcccggacc cctgaggtca cgtgcgtggt ggtggacgtg       180
     agccacgaag accccgaggt ccagttcaag tggtacgtgg acggcgtgga ggtgcataat       240
//
ID   A02367; SV 1; linear; unassigned DNA; STD; SYN; 401 BP.
XX
AC   A02367;
XX
DT   31-OCT-2001 (Rel. 200144-3, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 5)
XX
DE   Synthetic CH2 domain of mouse IgG2b antibody gene.
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; IG-Heavy-Gamma; IG-Heavy-Gamma-2-b-IGHG2B;
KW   IG-Heavy-Gamma-2-IGHG2; regular; unassigned DNA; undefined;
KW   synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-401
RA   ;
RT   "ALTERED ANTIBODIES";
RL   Patent number WO8807089-A/9, 22-SEP-1988.
XX
DR   ENA; A02367.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..401
FT                   /db_xref="taxon:32630"
FT                   /mol_type="unassigned DNA"
FT                   /organism="synthetic construct"
FT   CDS             <54..>383
FT                   /note="with mutations"
FT                   /transl_table=11
FT                   /product="CH2 IgG2b antibody"
FT                   /protein_id="CAA00242.1"
FT                   /translation="APNLEGGPSVFIFPPNIKDVLMISLTPKVTCVVVDVSEDDPDVQI
FT                   SWFVNNVEVHTAQTQTHREDYNSTIRVVSTLPIQHQDWMSGKEFKCKVNNKDLPSPIER
FT                   TISKIK"
XX
SQ   Sequence 401 BP; 118 A; 112 C; 90 G; 81 T; 0 other;
     ccctgtaatg gaggataagc catgtacaaa tccatttcca tctctcctca tcagctccta        60
     acctcgaggg tggaccatcc gtcttcatct tccctccaaa tatcaaggat gtactcatga       120
     tctccctgac acccaaggtc acgtgtgtgg tggtggatgt gagcgaggat gacccagacg       180
     tccagatcag ctggtttgtg aacaacgtgg aagtacacac agctcagaca caaacccata       240
     gagaggatta caacagtact atccgggtgg tcagcaccct ccccatccag caccaggact       300
     ggatgagtgg caaggagttc aaatgcaagg tcaacaacaa agacctccca tcacccatcg       360
     agagaaccat ctcaaaaatt aaaggtggga cctgcaggac a                           401
//
ID   A02856; SV 1; linear; unassigned DNA; PAT; SYN; 894 BP.
XX
AC   A02856;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   06-OCT-2012 (Rel. 201240-6, Last updated, Version 3)
XX
DE   Artificial sequence for ZZ-IGF-I
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   scFv; patent; unassigned DNA; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-894
RA   Loewenadler B., Holmgren E., Uhlen M., Nilsson B.;
RT   "Preparation of fused proteins, antibodies and processes therefore.";
RL   Patent number EP0243333-A/4, 28-OCT-1987.
RL   KabiGen AB.
XX
DR   ENA; A02856.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..894
FT                   /organism="synthetic construct"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32630"
FT   CDS             184..888
FT                   /transl_table=11
FT                   /product="ZZ-IGF-1"
FT                   /protein_id="CAA00282.1"
FT                   /translation="MKKKNIYSIRKLGVGIASVTLGTLLISGXVTPAANAAQHDEAVDN
FT                   KFNKEQQNAFYEILHLPNLNEEQRNAFIQSLKDDPSQSANLLAEAKKLNDAQAPKVDNK
FT                   FNKEQQNAFYEILHLPNLNEEQRNAFIQSLKDDPSQSANLLAEAKKLNDAQAPKVDANS
FT                   NGPETLCGAELVDPLQFVCGDRGFYFNKPTAYGSSSRRAPQTGIVDECCFRSCDLRRLE
FT                   MYCAPLKPAKSA"
XX
SQ   Sequence 894 BP; 295 A; 185 C; 157 G; 256 T; 1 other;
     tcgaaatagc gtgattttgc ggttttaagc cttttacttc ctgaataaat ctttcagcaa        60
     aatatttatt ttataagttg taaaacttac ctttaaattt aattataaat atagatttta       120
     gtattgcaat acataattcg ttatattatg atgactttac aaatacatac agggggtatt       180
     aatttgaaaa agaaaaacat ttattcaatt cgtaaactag gtgtaggtat tgcatctgta       240
     actttaggta cattacttat atctggtgnc gtaacacctg ctgcaaatgc tgcgcaacac       300
     gatgaagccg tagacaacaa attcaacaaa gaacaacaaa acgcgttcta tgagatctta       360
     catttaccta acttaaacga agaacaacga aacgccttca tccaaagttt aaaagatgac       420
     ccaagccaaa gcgctaacct tttagcagaa gctaaaaagc taaatgatgc tcaggcgccg       480
     aaagtagaca acaaattcaa caaagaacaa caaaacgcgt tctatgagat cttacattta       540
     cctaacttaa acgaagaaca acgaaacgcc ttcatccaaa gtttaaaaga tgacccaagc       600
     caaagcgcta accttttagc agaagctaaa aagctaaatg atgctcaggc gccgaaagta       660
     gacgcgaatt ctaacggtcc cgaaactctg tgcggtgctg aactggttga ccctctgcag       720
     tttgtttgcg gtgaccgtgg tttttatttt aacaaaccca ctgcttatgg ttcttcttct       780
     cgtcgtgctc cccagactgg tattgttgac gaatgctgct ttcgttcttg cgacctgcgt       840
     cgtctggaaa tgtattgcgc tcccctgaaa cccgctaaat ctgcttagaa gctt             894
//
ID   A03900; SV 1; linear; unassigned DNA; PAT; HUM; 611 BP.
XX
AC   A03900;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   H.sapiens HuV(NP) gene
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; diversity; joining; patent; regular; unassigned DNA; rearranged.
XX
OS   Homo sapiens (human)
OC   cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria;
OC   Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi;
OC   Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota;
OC   Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates;
OC   Haplorrhini; Simiiformes; Catarrhini; Hominoidea; Hominidae; Homininae;
OC   Homo; Homo sapiens.
XX
RN   [1]
RP   1-611
RA   ;
RT   "Recombinant antibodies and methods for their production.";
RL   Patent number EP0239400-A/3, 30-SEP-1987.
RL   MEDICAL RESEARCH COUNCIL.
XX
DR   ENA; A03900.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..611
FT                   /organism="Homo sapiens"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:9606"
FT   CDS             join(110..155,238..609)
FT                   /partial
FT                   /gene="HuV(NP)"
FT                   /protein_id="CAA00307.1"
FT                   /translation="MGWSCIILFLVATATGVHSQVQLQESGPGLVRPSQTLSLTCTVSG
FT                   STFSSYWMHWVRQPPGRGLEWIGRIDPNSGGTKYNEKFKSRVTMLVDTSKNQFSLRLSS
FT                   VTAADTAVYYCARYDYYGSSYFDYWGQGSLVTVSS"
FT   mat_peptide     join(155,238..609)
FT                   /partial
FT                   /gene="HuV(NP)"
FT   intron          156..237
FT                   /number=1
FT   exon            110..155
FT                   /number=1
FT   exon            238..609
FT                   /number=2
FT   sig_peptide     110..154
XX
SQ   Sequence 611 BP; 163 A; 152 C; 155 G; 141 T; 0 other;
     atgcaaatcc tctgaatcta catggtaaat ataggtttgt ctataccaca aacagaaaaa        60
     catgagatca cagttctctc tacagttact gagcacacag gacctcacca tgggatggag       120
     ctgtatcatc ctcttcttgg tagcaacagc tacaggtaag gggctcacag tagcaggctt       180
     gaggtctgga catatatatg ggtgacaatg acatccactt tgcctttctc tccacaggtg       240
     tccactccca ggtccaactg caggagagcg gtccaggtct tgtgagacct agccagaccc       300
     tgagcctgac ctgcaccgtg tctggcagca ccttcagcag ctactggatg cactgggtga       360
     gacagccacc tggacgaggt cttgagtgga ttggaaggat tgatcctaat agtggtggta       420
     ctaagtacaa tgagaagttc aagagcagag tgacaatgct ggtagacacc agcaagaacc       480
     agttcagcct gagactcagc agcgtgacag ccgccgacac cgcggtctat tattgtgcaa       540
     gatacgatta ctacggtagt agctactttg actactgggg tcaaggcagc ctcgtcacag       600
     tctcctcagg t                                                            611
//
ID   A03903; SV 1; linear; unassigned DNA; PAT; UNC; 39 BP.
XX
AC   A03903;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   Oligonucleotide D1.3 CDR1
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; patent; regular; unassigned DNA.
XX
OS   unidentified
OC   unclassified sequences; unidentified.
XX
RN   [1]
RP   1-39
RA   ;
RT   "Recombinant antibodies and methods for their production.";
RL   Patent number EP0239400-A/6, 30-SEP-1987.
RL   MEDICAL RESEARCH COUNCIL.
XX
DR   ENA; A03903.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..39
FT                   /organism="unidentified"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32644"
XX
SQ   Sequence 39 BP; 8 A; 13 C; 8 G; 10 T; 0 other;
     ctgtctcacc cagtttacac catagccgct gaaggtgct                               39
//
ID   A03904; SV 1; linear; unassigned DNA; PAT; UNC; 72 BP.
XX
AC   A03904;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   Oligonucleotide D1.3 CDR2
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; patent; regular; unassigned DNA.
XX
OS   unidentified
OC   unclassified sequences; unidentified.
XX
RN   [1]
RP   1-72
RA   ;
RT   "Recombinant antibodies and methods for their production.";
RL   Patent number EP0239400-A/7, 30-SEP-1987.
RL   MEDICAL RESEARCH COUNCIL.
XX
DR   ENA; A03904.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..72
FT                   /organism="unidentified"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32644"
XX
SQ   Sequence 72 BP; 18 A; 20 C; 10 G; 24 T; 0 other;
     cattgtcact ctggatttga gagctgaatt atagtctgtg tttccatcac cccaaatcat        60
     tccaatccac tc                                                            72
//
ID   A03905; SV 1; linear; unassigned DNA; PAT; UNC; 48 BP.
XX
AC   A03905;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   Oligonucleotide D1.3 CDR3
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; patent; regular; unassigned DNA.
XX
OS   unidentified
OC   unclassified sequences; unidentified.
XX
RN   [1]
RP   1-48
RA   ;
RT   "Recombinant antibodies and methods for their production.";
RL   Patent number EP0239400-A/8, 30-SEP-1987.
RL   MEDICAL RESEARCH COUNCIL.
XX
DR   ENA; A03905.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..48
FT                   /organism="unidentified"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32644"
XX
SQ   Sequence 48 BP; 12 A; 16 C; 6 G; 14 T; 0 other;
     gccttgaccc cagtagtcaa gcctataatc tctctctctt gcacaata                     48
//
ID   A03907; SV 1; linear; unassigned DNA; PAT; HUM; 412 BP.
XX
AC   A03907;
XX
DT   11-MAR-1998 (Rel. 199811-3, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 5)
XX
DE   H.sapiens antibody D1.3 variable region protein
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; variable; diversity; joining; patent; regular; unassigned DNA;
KW   rearranged.
XX
OS   Homo sapiens (human)
OC   cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria;
OC   Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi;
OC   Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota;
OC   Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates;
OC   Haplorrhini; Simiiformes; Catarrhini; Hominoidea; Hominidae; Homininae;
OC   Homo; Homo sapiens.
XX
RN   [1]
RP   1-412
RA   ;
RT   "Recombinant antibodies and methods for their production.";
RL   Patent number EP0239400-A/10, 30-SEP-1987.
RL   MEDICAL RESEARCH COUNCIL.
XX
DR   ENA; A03907.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..412
FT                   /organism="Homo sapiens"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:9606"
FT   V_region        8..>412
FT                   /note="antibody D1.3 V region"
FT   sig_peptide     8..64
FT   CDS             8..>412
FT                   /product="antibody D1.3 V region (VDJ)"
FT                   /protein_id="CAA00308.1"
FT                   /translation="MAVLALLFCLVTFPSCILSQVQLKESGPGLVAPSQSLSITCTVSG
FT                   FSLTGYGVNWVRQPPGKGLEWLGMIWGDGNTDYNSALKSRLSISKDNSKSQVFLKMNSL
FT                   HTDDTARYYCARERDYRLDYWGQGTTLTVSS"
FT   D_segment       356..371
FT   J_segment       372..>412
FT                   /note="J(H)2 region"
XX
SQ   Sequence 412 BP; 105 A; 109 C; 104 G; 94 T; 0 other;
     tcagagcatg gctgtcctgg cattactctt ctgcctggta acattcccaa gctgtatcct        60
     ttcccaggtg cagctgaagg agtcaggacc tggcctggtg gcgccctcac agagcctgtc       120
     catcacatgc accgtctcag ggttctcatt aaccggctat ggtgtaaact gggttcgcca       180
     gcctccagga aagggtctgg agtggctggg aatgatttgg ggtgatggaa acacagacta       240
     taattcagct ctcaaatcca gactgagcat cagcaaggac aactccaaga gccaagtttt       300
     cttaaaaatg aacagtctgc acactgatga cacagccagg tactactgtg ccagagagag       360
     agattatagg cttgactact ggggccaagg caccactctc acagtctcct ca               412
//
ID   A04195; SV 1; linear; cDNA; STD; SYN; 51 BP.
XX
AC   A04195;
XX
DT   15-MAY-1995 (Rel. 199520-1, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 5)
XX
DE   Artificial Ig lambda-chain mRNA
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Light; IG-Light-Lambda-IGL; regular; cDNA; rearranged;
KW   synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-51
RA   ;
RT   ;
RL   Patent number WO8403712-A/4, 27-SEP-1984.
XX
DR   ENA; A04195.
XX
CC   IMGT/LIGM-DB annotation level: by annotators
XX
FH   Key                 Location/Qualifiers
FH   
FT   L-REGION            10..51
FT                       /partial
FT                       /translation="MQAVMTQESALTTS"
FT                       /organism="Artificial sequence"
FT                       /product="Ig Lambda"
FT   INIT-CODON          10..12
XX
SQ   Sequence 51 BP; 15 A; 13 C; 10 G; 13 T; 0 other;
     gattgatcaa tgcaggctgt tatgactcag gaatctgcac tcaccacatc a                 51
//
ID   A04228; SV 1; linear; cDNA; STD; SYN; 35 BP.
XX
AC   A04228;
XX
DT   11-MAR-1998 (Rel. 199811-3, arrived in LIGM-DB)
DT   20-APR-1999 (Rel. 199916-2, Last updated, Version 2)
XX
DE   Artificial Ig mu-chain mRNA
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; IG-Heavy-Mu; cDNA; rearranged; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-35
RA   ;
RT   ;
RL   Patent number WO8403712-A/40, 27-SEP-1984.
XX
DR   ENA; A04228.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..35
FT                   /organism="synthetic construct"
XX
SQ   Sequence 35 BP; 10 A; 7 C; 11 G; 7 T; 0 other;
     aagggtatga tcaatgcagg ttcagctgca gcagc                                   35
//
ID   A04229; SV 1; linear; cDNA; STD; SYN; 36 BP.
XX
AC   A04229;
XX
DT   11-MAR-1998 (Rel. 199811-3, arrived in LIGM-DB)
DT   20-APR-1999 (Rel. 199916-2, Last updated, Version 2)
XX
DE   Artificial Ig mu-chain mRNA
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; IG-Heavy-Mu; cDNA; rearranged; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-36
RA   ;
RT   ;
RL   Patent number WO8403712-A/41, 27-SEP-1984.
XX
DR   ENA; A04229.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..36
FT                   /organism="synthetic construct"
XX
SQ   Sequence 36 BP; 12 A; 8 C; 9 G; 7 T; 0 other;
     aaggtattgc acatatgcaa gtgcaactgc agcagc                                  36
//
ID   A04230; SV 1; linear; cDNA; STD; SYN; 36 BP.
XX
AC   A04230;
XX
DT   11-MAR-1998 (Rel. 199811-3, arrived in LIGM-DB)
DT   20-APR-1999 (Rel. 199916-2, Last updated, Version 2)
XX
DE   Artificial Ig mu-chain mRNA
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; IG-Heavy-Mu; cDNA; rearranged; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-36
RA   ;
RT   ;
RL   Patent number WO8403712-A/42, 27-SEP-1984.
XX
DR   ENA; A04230.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..36
FT                   /organism="synthetic construct"
XX
SQ   Sequence 36 BP; 10 A; 8 C; 10 G; 8 T; 0 other;
     aaggtattgc acatatgcag gttcagctgc agcagc                                  36
//
ID   A04231; SV 1; linear; cDNA; STD; SYN; 31 BP.
XX
AC   A04231;
XX
DT   11-MAR-1998 (Rel. 199811-3, arrived in LIGM-DB)
DT   20-APR-1999 (Rel. 199916-2, Last updated, Version 2)
XX
DE   Artificial Ig mu-chain mRNA
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; IG-Heavy-Mu; cDNA; rearranged; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-31
RA   ;
RT   ;
RL   Patent number WO8403712-A/43, 27-SEP-1984.
XX
DR   ENA; A04231.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..31
FT                   /organism="synthetic construct"
XX
SQ   Sequence 31 BP; 11 A; 5 C; 9 G; 6 T; 0 other;
     aagggtatga tcaatgcaag tgcaactgca g                                       31
//
ID   A05232; SV 1; linear; unassigned DNA; PAT; SYN; 28 BP.
XX
AC   A05232;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   06-OCT-2012 (Rel. 201240-6, Last updated, Version 3)
XX
DE   Artificial sequence fig 2 from page 1/6
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   scFv; patent; unassigned DNA; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-28
RA   Loewenadler B., Holmgren E., Uhlen M., Nilsson B.;
RT   "Preparation of fused proteins, antibodies and processes therefore.";
RL   Patent number EP0243333-A/9, 28-OCT-1987.
RL   KabiGen AB.
XX
DR   ENA; A05232.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..28
FT                   /organism="synthetic construct"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32630"
XX
SQ   Sequence 28 BP; 5 A; 9 C; 9 G; 5 T; 0 other;
     gaattcccgg ggatccgtcg acctgcag                                           28
//
ID   A05422; SV 1; linear; unassigned DNA; PAT; SYN; 817 BP.
XX
AC   A05422;
XX
DT   12-JUN-2003 (Rel. 200324-4, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   Synthetic M13-VHPCR1 sequence of Ig variable region
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Heavy; variable; diversity; joining; patent; regular; unassigned DNA;
KW   rearranged; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-817
RA   ;
RT   ;
RL   Patent number WO9005144-A/46, 17-MAY-1990.
XX
DR   ENA; A05422.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..817
FT                   /organism="synthetic construct"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32630"
FT   CDS             join(122..166,249..>620)
FT                   /transl_table=11
FT                   /note="M13-VHPCR1 sequence"
FT                   /protein_id="CAA00454.1"
FT                   /translation="MGWSCIILFLVATATGVHSQVQLQESGPGLVRPSQTLSLTCTVSG
FT                   STFSSYWMHWVRQPPGRGLEWIGRIDPNSGGTKYNEKFKSRVTMLVDTSKNQFSLRLSS
FT                   VTAADTAVYYCARYDYYGSSYFDYWGQGTTVTVSS"
FT   exon            122..166
FT                   /number=1
FT   exon            249..>620
FT                   /number=2
FT   intron          167..248
FT                   /number=1
XX
SQ   Sequence 817 BP; 217 A; 194 C; 209 G; 197 T; 0 other;
     aagcttatga atatgcaaat cctctgaatc tacatggtaa atataggttt gtctatacca        60
     caaacagaaa aacatgagat cacagttctc tctacagtta ctgagcacac aggacctcac       120
     catgggatgg agctgtatca tcctcttctt ggtagcaaca gctacaggta aggggctcac       180
     agtagcaggc ttgaggtctg gacatatata tgggtgacaa tgacatccac tttgcctttc       240
     tctccacagg tgtccactcc caggtccaac tgcaggagag cggtccaggt cttgtgagac       300
     ctagccagac cctgagcctg acctgcaccg tgtctggcag caccttcagc agctactgga       360
     tgcactgggt gagacagcca cctggacgag gtcttgagtg gattggaagg attgatccta       420
     atagtggtgg tactaagtac aatgagaagt tcaagagcag agtgacaatg ctggtagaca       480
     ccagcaagaa ccagttcagc ctgagactca gcagcgtgac agccgccgac accgcggtct       540
     attattgtgc aagatacgat tactacggta gtagctactt tgactactgg ggccaaggga       600
     ccacggtcac cgtctcctca ggtgagtcct tacaacctct ctcttctatt cagcttaaat       660
     agattttact gcatttgttg ggggggaaat gtgtgtatct gaatttcagg tcatgaagga       720
     ctagggacac cttgggagtc agaaagggtc attgggagcc cgggctgatg cagacagaca       780
     tcctcagctc ccagacttca tggccagaga tttatag                                817
//
ID   A05424; SV 1; linear; unassigned DNA; PAT; SYN; 620 BP.
XX
AC   A05424;
XX
DT   12-JUN-2003 (Rel. 200324-4, arrived in LIGM-DB)
DT   14-JAN-2013 (Rel. 201303-1, Last updated, Version 4)
XX
DE   Synthetic M13-VKPCR1 sequence of Ig variable region
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   IG-Light; IG-Light-Kappa-IGK; variable; joining; patent; regular;
KW   unassigned DNA; rearranged; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-620
RA   ;
RT   ;
RL   Patent number WO9005144-A/48, 17-MAY-1990.
XX
DR   ENA; A05424.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..620
FT                   /organism="synthetic construct"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32630"
FT   CDS             join(122..166,249..>584)
FT                   /transl_table=11
FT                   /note="M13-VKPCR1"
FT                   /protein_id="CAA00455.1"
FT                   /translation="MGWSCIILFLVATATGVHSDIQLTQSPSSLSASVGDRVTITCRAS
FT                   GNIHNYLAWYQQKPGKAPKLLIYYTTTLADGVPSRFSGSGSGTDFTFTISSLQPEDIAT
FT                   YYCQHFWSTPRTFGQGTKVVIKR"
FT   exon            122..166
FT                   /number=1
FT   exon            249..>584
FT                   /number=2
FT   intron          167..248
FT                   /number=1
XX
SQ   Sequence 620 BP; 168 A; 175 C; 144 G; 133 T; 0 other;
     aagcttatga atatgcaaat cctctgaatc tacatggtaa atataggttt gtctatacca        60
     caaacagaaa aacatgagat cacagttctc tctacagtta ctgagcacac aggacctcac       120
     catgggatgg agctgtatca tcctcttctt ggtagcaaca gctacaggta aggggctcac       180
     agtagcaggc ttgaggtctg gacatatata tgggtgacaa tgacatccac tttgcctttc       240
     tctccacagg tgtccactcc gacatccagc tgacccagag cccaagcagc ctgagcgcca       300
     gcgtgggtga cagagtgacc atcacctgta gagccagcgg taacatccac aactacctgg       360
     cttggtacca gcagaagcca ggtaaggctc caaagctgct gatctactac accaccaccc       420
     tggctgacgg tgtgccaagc agattcagcg gtagcggtag cggtaccgac ttcaccttca       480
     ccatcagcag cctccagcca gaggacatcg ccacctacta ctgccagcac ttctggagca       540
     ccccaaggac gttcggccaa gggaccaagg tggtgatcaa acgtgagtag aatttaaact       600
     ttgcttcctc agttggatcc                                                   620
//
ID   A06333; SV 1; linear; unassigned DNA; PAT; SYN; 39 BP.
XX
AC   A06333;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   06-OCT-2012 (Rel. 201240-6, Last updated, Version 3)
XX
DE   Artificial pEX8-mer sequence
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   scFv; patent; unassigned DNA; synthetic construct.
XX
OS   Synthetic construct (synthetic construct)
OC   other sequences; artificial sequences; Synthetic construct.
XX
RN   [1]
RP   1-39
RA   Oltersdorf T., Roewekamp W., Schneider-Gaedicke A., Seedorf K., Duerst M.,
RA   Schwarz E.;
RT   "Expression products of human papilloma virus type 18, antibodies specific
RT   for these proteins, and diagnostic reagents containing these antibodies or
RT   the corresponding DNA.";
RL   Patent number EP0256321-A/10, 24-FEB-1988.
RL   BEHRINGWERKE Aktiengesellschaft.
XX
DR   ENA; A06333.
XX
CC   IMGT/LIGM-DB annotation level: keyword level
XX
FH   Key             Location/Qualifiers (from EMBL)
FH   
FT   source          1..39
FT                   /organism="synthetic construct"
FT                   /mol_type="unassigned DNA"
FT                   /db_xref="taxon:32630"
XX
SQ   Sequence 39 BP; 7 A; 12 C; 12 G; 8 T; 0 other;
     ctgaattccg gggatccgtc gacctgcagc caagcttgg                               39
//
ID   A06335; SV 1; linear; unassigned DNA; PAT; SYN; 39 BP.
XX
AC   A06335;
XX
DT   24-MAY-2002 (Rel. 200221-5, arrived in LIGM-DB)
DT   06-OCT-2012 (Rel. 201240-6, Last updated, Version 3)
XX
DE   Artificial pEX10-mer sequence
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); immunoglobulin (IG);
KW   scFv; patent; unassigned DNA; synthetic construct.
